We build breakthrough biotechs

Biotech

Creating and building breakthrough biotechs for over 30 years

People

Partnering with the world's best life science entrepreneurs

Impact

Translating groundbreaking science into life-changing medicines
Scroll to explore
3
Latest news
Eli Lilly acquires cancer program from Scorpion Therapeutics in $2.5B deal
Find out more
Atlas Venture 2024 Newsletter
Find out more
Chroma, Nvelop merge to form nChroma Bio, raising $75M to enter the clinic
Find out more

Thirty years at the leading-edge of medical innovation and we’re just getting started.

Discover Portfolio Team
~ Measuring our impact

>25

Medicines made by Atlas portfolio companies

~ Measuring our impact

70

Startups launched from the Atlas incubator

~ Measuring our impact

40

IPOs

~ Measuring our impact

34

M&A Exits

01